Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Invested Capital (2021 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Return on Invested Capital data on record, last reported at 0.54% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 27.0% year-over-year to 0.54%; the TTM value through Dec 2025 reached 0.54%, down 27.0%, while the annual FY2025 figure was 0.49%, 25.0% down from the prior year.
  • Return on Invested Capital reached 0.54% in Q4 2025 per MRVI's latest filing, down from 0.29% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.5% in Q1 2022 and bottomed at 0.54% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.1%, with a median of 0.15% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: increased 27bps in 2022, then plummeted -42bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.48% in 2021, then dropped by -23bps to 0.36% in 2022, then crashed by -99bps to 0.01% in 2023, then tumbled by -5243bps to 0.27% in 2024, then tumbled by -103bps to 0.54% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.54% in Q4 2025, 0.29% in Q3 2025, and 0.4% in Q2 2025.